-
公开(公告)号:AU2003266585A1
公开(公告)日:2004-07-29
申请号:AU2003266585
申请日:2003-09-24
Applicant: NEW IND RES ORGANIZATION
Inventor: ISHIDO SATOSHI
-
22.
公开(公告)号:AU2003244286A1
公开(公告)日:2004-01-06
申请号:AU2003244286
申请日:2003-06-19
Applicant: NEW IND RES ORGANIZATION
Inventor: YANAGI SHIGERU
-
公开(公告)号:AU1092602A
公开(公告)日:2002-05-06
申请号:AU1092602
申请日:2001-10-24
Applicant: NEW IND RES ORGANIZATION , SHIOZAWA SHUNICHI
Inventor: SHIOZAWA SHUNICHI , KONISHI YOSHITAKE
Abstract: Mutations in a genome associating in rheumatoid arthritis (RA) are found in human DR3 genomic DNA having the base sequence represented by SEQ ID NO:1. The invention provides a genome having such mutations, transcripts thereof, a method of highly accurately evaluating the RA onset or the RA onset possibility by using the mutations thereof, an evaluation kit therefor, and a therapeutic method and remedies for RA.
-
公开(公告)号:MX9702773A
公开(公告)日:1998-04-30
申请号:MX9702773
申请日:1995-11-08
Applicant: DU PONT , COMMW SCIENT IND RES ORG , IND RES ORGANIZATION
Inventor: MOAD GRAEME , MOAD CATHERINE LOUISE , KRSTINA JULIA , RIZZARDO EZIO , BERGE CHARLES THOMAS , DARLING THOMAS ROBERT
IPC: C08F2/22 , C08F2/38 , C08F12/02 , C08F12/08 , C08F20/00 , C08F290/04 , C08F293/00
Abstract: Procedimiento para la síntesis de polímeros, homopolímeros y copolímeros de bloque de polidispersabilidad reducida, que tienen la formula (1) al poner en contacto monomero(s) de vinilo seleccionad(s), compuesto(s) terminado(s) en vinilo y radicales libres en los cuales el control efectivo de la produccion de polímero se logra al controlar la relacion en mol de el(los) monomero(s) de vinilo. Compuesto(s) terminados en vinilo y radicales libres con relacion entre sí; y polímeros producidos por el mismo.
-
公开(公告)号:CA2982617A1
公开(公告)日:2016-10-20
申请号:CA2982617
申请日:2016-04-15
Applicant: COMMONWEALTH SCIENT AND IND RES ORGANIZATION
Inventor: DOUGLAS GRANT BRIAN
Abstract: A process for selectively separating a metallic constituent from other metals and other materials accompanying the metallic constituent in a mixture is described. The process comprises the step of providing the mixture in an aqueous solution such that the metallic constituent forms a complex anion in the solution. One or more of the other metals forms a cation or a complex cation in the solution. Another step includes contacting the solution with one or more additives to form layered double hydroxide (LDH) material in situ such that the complex anion is intercalated within interlayers of the LDH material and wherein one or more of the other metals are incorporated into the LDH material's crystal structure or matrix. Another step involves the addition of an LDH to an aqueous solution. The process involves selectively recovering the metallic constituent from the interlayer of the LDH by subjecting the LDH to a recovery treatment step(s) and as required, methods to modify the LDH to facilitate metal separation and recovery or contaminant stabilisation.
-
26.
公开(公告)号:NZ560887A
公开(公告)日:2009-10-30
申请号:NZ56088706
申请日:2006-02-03
Applicant: NEW IND RES ORGANIZATION
Inventor: TSUJI SOICHI , MANNEN HIDEYUKI
IPC: C12N15/09 , A01K67/027 , C07K14/47 , C12Q1/68
Abstract: Disclosed is a method for evaluating cattle able to produce a better quality beef comprising the steps: (a) determining whether or not a gene encoding the sterol regulatory element binding protein (SREBP-1) has a deletion in the 85th to 168th bases of its fifth intron; (b) determining whether the SREBP-1 gene has an "S type" or an "L type" allele, said "S type" allele having a shorter fifth intron due to deletion in the 85th to 168th bases with said "L type" allele being free from the deletion in the 85th to 168th bases and having a longer fifth intron: and (c) evaluating the cattle with an "S type" allele to produce a better quality of beef compared with cattle with an "L type" allele. Further disclosed are specific bovine-derived SREBP-1 proteins, transgenic cattle, and methods for evaluating the unsaturated fatty acid content in beef fat by determining the whether a SREBP-1 and SCD genotype is present.
-
公开(公告)号:BRPI0606139A2
公开(公告)日:2009-06-02
申请号:BRPI0606139
申请日:2006-02-03
Applicant: NEW IND RES ORGANIZATION
Inventor: TSUJI SOICHI , MANNEN HIDEYUKI
IPC: C12N15/09 , A01K67/027 , C07K14/47 , C12Q1/68
-
公开(公告)号:DE10394092T5
公开(公告)日:2005-12-22
申请号:DE10394092
申请日:2003-12-02
Applicant: NEW IND RES ORGANIZATION
Inventor: OSHIMA MASAHIRO , MAE KAZUHIRO , HASHIMOTO IORI , HASEBE SHINJI , OKUMA OSAMU , HIRANO TAKAYUKI
-
公开(公告)号:CA2542335A1
公开(公告)日:2005-04-28
申请号:CA2542335
申请日:2004-10-15
Applicant: NEW IND RES ORGANIZATION
Inventor: SHIRAKAWA TOSHIRO , HAMADA KATSUYUKI , GOTO AKINOBU
IPC: A61K48/00 , A61K31/409 , A61K33/26 , A61K35/12 , A61K35/13 , A61K35/76 , A61K35/761 , A61K35/763 , A61K35/765 , A61K35/766 , A61K39/12 , A61K47/42 , A61P35/00 , C07K14/475 , C12N15/00 , C12N15/85 , C12N15/861
Abstract: An oncogene therapeutic drug which comprises a combination of a virus for an immunological treatment to be administered for inducing a CTL reaction withi n the living bodywith a carrier cell having been infected with an oncolytic virus before administration so as to treat a tumor cell with the virus withi n the living body. As the carrier cell, use can be made of, for example, an A5 49 cell. As the virus for an immunological treatment, use can be made of, for example, a non-proliferative adenovirus having been inactivated by UV irradiation. As the oncolytic virus, use can be made of, for example, a proliferative adenovirus having a tumor-specific promoter.
-
公开(公告)号:AU2003289053A1
公开(公告)日:2004-06-30
申请号:AU2003289053
申请日:2003-12-12
Applicant: NEW IND RES ORGANIZATION
Inventor: KATAOKA NOBUMASA , NAKAHARA MORIO
-
-
-
-
-
-
-
-
-